CHICAGO EQUITY PARTNERS LLC - IMMUNOGEN INC ownership

IMMUNOGEN INC's ticker is IMGN and the CUSIP is 45253H101. A total of 183 filers reported holding IMMUNOGEN INC in Q3 2017. The put-call ratio across all filers is 0.79 and the average weighting 0.1%.

Quarter-by-quarter ownership
CHICAGO EQUITY PARTNERS LLC ownership history of IMMUNOGEN INC
ValueSharesWeighting
Q4 2019$437,000
+41.9%
85,660
-32.7%
0.02%
+66.7%
Q3 2019$308,000
-35.0%
127,305
+154.6%
0.02%
+7.1%
Q3 2018$474,000
-90.7%
50,006
-90.5%
0.01%
-91.1%
Q2 2018$5,124,000
-3.3%
526,660
+4.5%
0.16%
-7.1%
Q1 2018$5,300,000
+69.1%
503,765
+3.0%
0.17%
+76.0%
Q4 2017$3,135,000
-16.5%
489,035
-0.3%
0.10%
-19.3%
Q3 2017$3,753,000
+141.8%
490,635
+124.7%
0.12%
+183.3%
Q2 2017$1,552,000218,3200.04%
Other shareholders
IMMUNOGEN INC shareholders Q3 2017
NameSharesValueWeighting ↓
QVT Financial LP 1,375,900$6,329,0001.08%
Redmile Group, LLC 12,006,979$55,232,0001.02%
Birchview Capital, LP 190,000$874,0000.53%
Fernwood Investment Management, LLC 179,340$825,0000.41%
HealthCor Management, L.P. 1,200,000$5,520,0000.23%
Grace Capital 49,500$228,0000.20%
TWIN FOCUS CAPITAL PARTNERS, LLC 104,068$479,0000.19%
Virtus ETF Advisers LLC 79,795$367,0000.17%
PINNACLE ASSOCIATES LTD 1,087,034$5,000,0000.12%
HUSSMAN STRATEGIC ADVISORS, INC. 100,000$460,0000.12%
View complete list of IMMUNOGEN INC shareholders